세계의 단일염기다형성(SNP) 지노타이핑 및 분석 시장 보고서(2025년)
SNP Genotyping And Analysis Global Market Report 2025
상품코드 : 1760716
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,527,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,434,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,341,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

단일염기다형성(SNP) 지노타이핑 및 분석 시장 규모는 향후 몇 년 동안 연평균 20.6%의 성장률을 기록하며 2029년까지 394억 1,000만 달러 규모로 성장할 것으로 예측됩니다. 예측 기간 동안의 성장은 집단 유전체학 개념의 확대, 희귀질환 진단에 대한 강조, 동반진단 및 정밀 종양학의 부상, DTC(Direct-to-Consumer) 유전체학에 대한 수요 증가, 유전체 의학에 대한 규제 당국의 지원 등에 의해 주도될 것으로 예측됩니다. 예측 기간 동안 예상되는 주요 동향으로는 유전체 분석 기술의 발전, 인공지능과 생물정보학의 통합, 종양학 연구의 발전, 법의학 및 가계 검사에서의 활용도 증가, 휴대용 유전체 분석 기기 개발 등이 있습니다.

유전성 질환의 유병률 증가는 단일염기다형성(SNP) 지노타이핑 시장의 성장을 가속할 것으로 예측됩니다. 유전성 질환은 DNA 이상에 의해 발생하며, DNA 이상은 한쪽 부모로부터 물려받거나 세포분열 시 돌연변이에 의해 발생합니다. 인식이 높아지고 진단 기술이 향상됨에 따라 더 많은 유전성 질환이 인식되고 진단되어 유전성 질환의 부담 증가에 기여하고 있으며, 단일염기다형성(SNP) 지노타이핑은 질병 위험, 진행, 약물 반응과 관련된 유전적 돌연변이를 확인하여 조기 진단 및 맞춤 치료를 가능하게 함으로써 중요한 역할을 하고 있습니다. 이에 중요한 역할을 하고 있습니다. 예를 들어, 낭포성 섬유증 호주가 2024년 2월에 발표한 보고서에 따르면, 호주의 낭포성 섬유증 환자 수는 2021년 3,616명에서 2022년 3,738명으로 증가했습니다. 이에 따라 유전성 질환의 부담 증가는 단일염기다형성(SNP) 지노타이핑 시장의 성장을 가속할 것으로 예측됩니다.

SNP 유전형질 분석 시장의 주요 기업들은 농업 분자 육종을 위한 대규모 로우패스 전장 유전체 염기서열 분석과 같은 첨단 솔루션 개발에 주력하고 있습니다. 농업용 전장유전체 시퀀싱은 작물이나 가축의 완전한 유전 물질을 해독하여 수확량, 내병성, 환경 적응성 등의 형질을 개선합니다. 예를 들어, 2024년 6월 중국 생명공학 기업 MGI Tech는 대규모 농업용 로우패스 전장 유전체 시퀀싱을 위한 효율적인 전체 워크플로우 솔루션을 발표했습니다. 이 솔루션은 DNA 추출, 라이브러리 준비, 시퀀싱, SNP &&InDel 콜링 등 농업 이배체 종의 분자 육종 유전형질 분석을 위해 설계되었으며, MGI의 DNBSEQ-T7 및 DNBSEQ-G400 시퀀서를 사용하여 초고처리량 처리량과 유연성을 제공하고, 돼지 참조 패널 및 데이터 분석 소프트웨어를 사용하여 맞춤형 데이터베이스를 만들지 않고도 유전형질을 효율적으로 분석할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

SNP genotyping and analysis involves detecting and studying single nucleotide polymorphisms (SNPs) variations at a single base pair in the genome across different individuals or populations. This is done using techniques such as PCR, microarrays, or sequencing. The process allows researchers to explore genetic diversity, track inheritance patterns, and gain insights into individual variations in drug responses or susceptibility to certain conditions.

The main sample types used in SNP genotyping and analysis include genomic DNA, RNA, cell-free DNA (cfDNA), plasma, and whole blood. Genomic DNA refers to the complete set of genetic material in an organism, which holds all the instructions needed for its growth and functioning. Various technologies are used to conduct the analysis, including microarrays, gene chips, TaqMan allelic discrimination, SNP pyrosequencing, Applied Biosciences SNPlex, and Sequenom MassArray MALDI-TOF. These methods serve different applications such as disease diagnostics, pharmacogenomics, precision medicine, forensic science, and agriculture. The target users for these technologies include hospitals, research labs, pharmaceutical and biotech companies, diagnostic labs, as well as academic and government institutions.

The SNP genotyping and analysis market research report is one of a series of new reports from The Business Research Company that provides SNP genotyping and analysis market statistics, including SNP genotyping and analysis industry global market size, regional shares, competitors with an SNP genotyping and analysis market share, detailed SNP genotyping and analysis market segments, market trends and opportunities, and any further data you may need to thrive in the SNP genotyping and analysis industry. This SNP genotyping and analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The SNP genotyping and analysis market size has grown rapidly in recent years. It will grow from $15.45 billion in 2024 to $18.65 billion in 2025 at a compound annual growth rate (CAGR) of 20.7%. The growth observed during the historical period can be credited to factors such as increased funding for biomedical research, the expansion of personalized medicine efforts, the rise of agricultural genomics, the high prevalence of chronic diseases, and the emergence of commercial genomic services.

The SNP genotyping and analysis market size is expected to see rapid growth in the next few years. It will grow to $39.41 billion in 2029 at a compound annual growth rate (CAGR) of 20.6%. The growth during the forecast period is expected to be driven by the expansion of population genomics initiatives, a stronger emphasis on diagnosing rare diseases, the rise in companion diagnostics and precision oncology, growing demand for direct-to-consumer (DTC) genomics, and regulatory support for genomic medicine. Key trends anticipated for the forecast period include advancements in genotyping technologies, the integration of artificial intelligence and bioinformatics, growth in oncology research, increased use in forensic and ancestry testing, and the development of portable genotyping devices.

The rising prevalence of genetic diseases is anticipated to drive the growth of the SNP genotyping and analysis market. Genetic diseases are caused by abnormalities in DNA, which may either be inherited from one or both parents or occur due to mutations during cell division. As awareness grows and diagnostic technologies improve, more genetic disorders are being recognized and diagnosed, contributing to the increasing burden of genetic diseases. SNP genotyping and analysis play a crucial role in this by identifying genetic variations linked to disease risk, progression, and drug responses, enabling early diagnosis and personalized treatment. For example, according to a report published by Cystic Fibrosis Australia in February 2024, the number of people living with cystic fibrosis in Australia increased to 3,738 in 2022, up from 3,616 in 2021. As a result, the growing burden of genetic diseases is expected to fuel the growth of the SNP genotyping and analysis market.

Leading companies in the SNP genotyping and analysis market are focusing on creating advanced solutions, such as large-scale low-pass whole genome sequencing for agricultural molecular breeding. Agricultural whole genome sequencing involves decoding the complete genetic material of crops or livestock to improve traits such as yield, disease resistance, and environmental adaptability. For instance, in June 2024, MGI Tech, a biotechnology company based in China, introduced an efficient whole workflow solution for large-scale agricultural low-pass whole genome sequencing. This solution, designed for molecular breeding genotyping of agricultural diploid species, includes DNA extraction, library preparation, sequencing, and SNP & InDel calling. It utilizes MGI's DNBSEQ-T7 and DNBSEQ-G400 sequencers, offering ultra-high throughput and flexibility, alongside pig reference panels and data analysis software to streamline genotyping without the need for custom database creation.

In January 2023, QIAGEN N.V., a Germany-based provider of sample and assay technologies, acquired Verogen, Inc. The acquisition aims to enhance QIAGEN's leadership in human identification and forensics by integrating Verogen's advanced NGS tools and bioinformatics solutions into its existing portfolio. Verogen, a U.S.-based biotechnology company, specializes in SNP genotyping and analysis, offering tools such as the Forenseq Kintelligence kit and universal analysis software for forensic applications.

Major players in the snp genotyping and analysis market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Eurofins Genomics Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Life Sciences Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., Azenta Life Sciences Inc., LGC Limited, Invitae Corporation, Oxford Nanopore Technologies Limited, Standard BioTools Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Sophia Genetics SA, Genedata AG, Genotypic Technology Private Limited, PREMIER Biosoft International.

North America was the largest region in the SNP genotyping and analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in SNP genotyping and analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the SNP genotyping and analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The SNP genotyping and analysis market consists of revenues earned by entities by providing services such as DNA extraction and quality control, whole genome SNP analysis, SNP chip services, genetic association studies, and bioinformatics analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The SNP genotyping and analysis market also includes sales of genotyping platforms, genotyping assays/kits, bioinformatics software, Axiom genome-wide arrays, and bioinformatics analysis tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

SNP Genotyping And Analysis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on snp genotyping and analysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for snp genotyping and analysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The snp genotyping and analysis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. SNP Genotyping And Analysis Market Characteristics

3. SNP Genotyping And Analysis Market Trends And Strategies

4. SNP Genotyping And Analysis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global SNP Genotyping And Analysis Growth Analysis And Strategic Analysis Framework

6. SNP Genotyping And Analysis Market Segmentation

7. SNP Genotyping And Analysis Market Regional And Country Analysis

8. Asia-Pacific SNP Genotyping And Analysis Market

9. China SNP Genotyping And Analysis Market

10. India SNP Genotyping And Analysis Market

11. Japan SNP Genotyping And Analysis Market

12. Australia SNP Genotyping And Analysis Market

13. Indonesia SNP Genotyping And Analysis Market

14. South Korea SNP Genotyping And Analysis Market

15. Western Europe SNP Genotyping And Analysis Market

16. UK SNP Genotyping And Analysis Market

17. Germany SNP Genotyping And Analysis Market

18. France SNP Genotyping And Analysis Market

19. Italy SNP Genotyping And Analysis Market

20. Spain SNP Genotyping And Analysis Market

21. Eastern Europe SNP Genotyping And Analysis Market

22. Russia SNP Genotyping And Analysis Market

23. North America SNP Genotyping And Analysis Market

24. USA SNP Genotyping And Analysis Market

25. Canada SNP Genotyping And Analysis Market

26. South America SNP Genotyping And Analysis Market

27. Brazil SNP Genotyping And Analysis Market

28. Middle East SNP Genotyping And Analysis Market

29. Africa SNP Genotyping And Analysis Market

30. SNP Genotyping And Analysis Market Competitive Landscape And Company Profiles

31. SNP Genotyping And Analysis Market Other Major And Innovative Companies

32. Global SNP Genotyping And Analysis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The SNP Genotyping And Analysis Market

34. Recent Developments In The SNP Genotyping And Analysis Market

35. SNP Genotyping And Analysis Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기